Affordable Access

Hypercholesterolaemia and lipid lowering treatment do not affect the acute endogenous fibrinolytic capacity in vivo.

Authors
Type
Published Article
Journal
Heart
1355-6037
Publisher
BMJ
Publication Date
Volume
87
Issue
1
Pages
48–53
Identifiers
PMID: 11751664
Source
Medline

Abstract

Hypercholesterolaemia and lipid lowering treatment cause no demonstrable effects on acute substance P induced t-PA release in vivo. This suggests that the preventative benefits of lipid lowering treatment are unlikely to be mediated by improvements in endogenous fibrinolysis.

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments
F